Controversial results were, however, reported from the study on human non-alcoholic fatty liver disease, showing that decreased activation of liver FXR was found in these patients and associated with increased expression of liver X receptor, SREBP-1c, and hepatic steatosis [79]. Here, NR1H4 is linked to Hepatic steatosis.